Ponatinib leukaemia drug molecule. Computer model showing the structure of a molecule of the tyrosine-kinase inhibitor (TKI) ponatinib. TKIs are the first-line therapy for most patients with chronic myelogenous leukaemia (CML),a form of blood cancer. Ponatinib is used for the treatment of CML and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / Andrade, Ramon / 3dciencia |
Bildgröße: | 3582 px × 5064 px |
Modell-Rechte: | nicht erforderlich |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: | - |